FDA GRANTS FAST TRACK DESIGNATION TO SOTIO’S SOT106 ADC FOR SOFT TISSUE SARCOMA TREATMENT, ACCELERATING CLINICAL DEVELOPMENT

Reuters · 3d ago

Please log in to view news